Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.

Oncotarget · 2015 · PMC4673229 · PMID 26299805

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In support of this latter scenario, APC and KRAS mutations frequently co-occur, while APC and BRAF mutations show a significant trend towards mutual exclusivity [ 10 , 11 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.